Early Life
Mario Germano Giuliani, a Swiss citizen, was born to a family with a rich history in the pharmaceutical industry. His great-grandfather, Germano Giuliani, founded the family's pharmaceutical company, Giuliani SpA, in Milan, Italy, in 1889. Giuliani's family has been involved in the pharmaceutical business for over a century.
Rise to Success
Giuliani's wealth is primarily derived from his investments in the healthcare sector. A key component of his wealth is his 8% stake in Royalty Pharma, a leading acquirer of pharmaceutical royalties. Royalty Pharma went public in 2020 and has collected revenue slices of blockbuster drugs. Giuliani also owns stakes in Swiss investment company HBM Healthcare Investments and a number of biotech firms in the U.S. He has held various executive positions and directorships in several companies.
Key Business Strategies
Giuliani's business strategy focuses on investments in the healthcare sector. Through Royalty Pharma, he has strategically invested in pharmaceutical royalties. The family also has investments in real estate. His directorships also include other healthcare-related companies like ElevateBio LLC. His focus on the healthcare sector showcases a deep understanding of market trends and opportunities.
Philanthropy
Information on specific philanthropic amounts is unavailable.